advertisement
Weinreb RN 56
Showing records 1 to 25 | Display all abstracts from Weinreb RN69392 Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Liu JH
American Journal of Ophthalmology 2016; 169: 249-257
69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Abe RY
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8
69393 Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Kawase K
Advances in Therapy 2016; 33: 1612-1627
69428 24-h monitoring devices and nyctohemeral rhythms of intraocular pressure
Aptel F
Progress in Retinal and Eye Research 2016; 55: 108-148
68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Medeiros FA
American Journal of Ophthalmology 2016; 168: 250-259
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Quaranta L
Advances in Therapy 2016; 33: 1305-1315
69386 Structural Change Can Be Detected in Advanced-Glaucoma Eyes
Belghith A
Investigative Ophthalmology and Visual Science 2016; 57: OCT511-8
69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Yarmohammadi A
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Biagioli E
Advances in Therapy 2016; 33: 1305-1315
69428 24-h monitoring devices and nyctohemeral rhythms of intraocular pressure
Weinreb RN
Progress in Retinal and Eye Research 2016; 55: 108-148
69392 Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Slight JR
American Journal of Ophthalmology 2016; 169: 249-257
69393 Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Vittitow JL
Advances in Therapy 2016; 33: 1612-1627
68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Martin KR
American Journal of Ophthalmology 2016; 168: 250-259
69386 Structural Change Can Be Detected in Advanced-Glaucoma Eyes
Medeiros FA
Investigative Ophthalmology and Visual Science 2016; 57: OCT511-8
69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Diniz-Filho A
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8
69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Zangwill LM
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Galli F
Advances in Therapy 2016; 33: 1305-1315
68994 Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
Peace J
American Journal of Ophthalmology 2016; 168: 250-259
69316 The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma
Zangwill LM
Investigative Ophthalmology and Visual Science 2016; 57: OCT421-8
69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Diniz-Filho A
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9
69386 Structural Change Can Be Detected in Advanced-Glaucoma Eyes
Bowd C
Investigative Ophthalmology and Visual Science 2016; 57: OCT511-8
69428 24-h monitoring devices and nyctohemeral rhythms of intraocular pressure
Chiquet C
Progress in Retinal and Eye Research 2016; 55: 108-148
69392 Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
Vittitow JL
American Journal of Ophthalmology 2016; 169: 249-257
69393 Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
Weinreb RN
Advances in Therapy 2016; 33: 1612-1627
69318 Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes
Suh MH
Investigative Ophthalmology and Visual Science 2016; 57: OCT451-9
